The plasma levels of activated thrombin activatable fibrinolysis inhibitor and thrombomodulin in Behçet Disease and their association with thrombosis
Makaleler > Tam Makale · 2010
Yazarlar: Ayhan DÖNMEZ, Kenan AKSU, Hakan AYDIN, Gökhan KESER, Seckin CAGIRGAN, EKER DOĞANAVŞARGİL, Murat TOMBULOĞLU
Thrombosis Research, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Wos, 2010, cilt 126, ss 207-210
DOI: 10.1016/j.thromres.2010.05.019
Özet
Objective: To investigate the plasma levels of activated thrombin activatable fibrinolysis inhibitor (aTAFI) and thrombomodulin (TM) in Behcet disease (BD) and their relationship with thrombosis.